Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 trial

Leukemia. 2010 Jul;24(7):1380-5. doi: 10.1038/leu.2010.111. Epub 2010 May 27.
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Comparative Study
  • Letter
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cohort Studies
  • Combined Modality Therapy
  • Daunorubicin / administration & dosage
  • Feasibility Studies
  • Female
  • Humans
  • Idarubicin / administration & dosage
  • Leukemia, Myeloid, Acute / pathology
  • Leukemia, Myeloid, Acute / therapy*
  • Male
  • Middle Aged
  • Peripheral Blood Stem Cell Transplantation*
  • Prospective Studies
  • Remission Induction
  • Survival Rate
  • Transplantation, Autologous
  • Treatment Outcome
  • Young Adult

Substances

  • Idarubicin
  • Daunorubicin